{
  "hash": "c2b05e4de6f76f6975c116f64dd80910",
  "result": {
    "engine": "knitr",
    "markdown": "---\neditor_options: \n   chunk_output_type: console\n---\n\n\n\n# ESRD Group Performance {#care-esrdgrp}\n\nThe __End-Stage Renal Disease (ESRD) Facility Aggregation Group Performance__ dataset provides performance information in the __ESRD Treatment Choices (ETC) Model__. \n\nThe dataset includes information on Performance Payment Adjustment (PPA), Modality Performance Score (MPS), home dialysis rate, and transplant rate, as well as the individual components of each rate for each model participant ESRD facility aggregation group. \n\n[All ESRD facilities within the same aggregation group share the same performance information. The supplementary aggregation group crosswalk file may be used to map aggregation groups to individual ETC Participant ESRD facilities.]{.aside}\n\n## Metadata\n\n::: {.cell}\n<pre class=\"r-output\"><code>       [ROWS] 421 \n   [MODIFIED] 2024-08-09 \n[PERIODICITY] Monthly [R/P1M] \n   [TEMPORAL] 2021-12-01 â€¢ 2023-06-30 \n [DICTIONARY] https://data.cms.gov/resources/esrd-facility-aggregation-group-performance-data-dictionary \n       [SITE] https://data.cms.gov/cms-innovation-center-programs/disease-episode-based-payment-models/end-stage-renal-disease-facility-aggregation-group-performance \n [REFERENCES] https://data.cms.gov/resources/esrd-treatment-choices-etc-model-methodology \n  [RESOURCES] https://data.cms.gov/data-api/v1/dataset-resources/4bae4223-a1dc-4b9c-bd7e-d9622461be35 \n   [DOWNLOAD] https://data.cms.gov/sites/default/files/2024-07/245da9ee-780e-41d3-8262-55a3c93c7f4a/ETC-MY4-DF-ModelDetailedResults.csv \n</code></pre>\n:::\n\n### Resources\n\n::: {.cell}\n<pre class=\"r-output\"><code>[ CSV] 2023 ESRD Facility Aggregation Group Performance Jun ( 54.5K)\n[ PDF] 2023 ESRD Facility Aggregation Group Performance Data Dictionary (852K)\n[ PDF] 2023 ETC Model Methodology (117.3K)\n[XLSX] 2023 ETC-MY2-AG-Crosswalk (436.3K)\n[XLSX] 2023 ETC-MY1-AG-Crosswalk (421.7K)\n[XLSX] 2023 ETC-MY3-AG-Crosswalk (411.7K)\n[XLSX] 2023 ETC-MY4-AG-Crosswalk (405.7K)\n</code></pre>\n:::\n\n### Dictionary\n\n::: {.cell}\n\n:::\n\n::: {.cell}\n::: {.cell-output-display}\n`````{=html}\n<pre class=\"r-output\"><code>\n```{=html}\n<div id=\"mpxckuhipz\" style=\"padding-left:0px;padding-right:0px;padding-top:10px;padding-bottom:10px;overflow-x:auto;overflow-y:auto;width:auto;height:auto;\">\n<style>@import url(\"https://fonts.googleapis.com/css2?family=Work+Sans:ital,wght@0,100;0,200;0,300;0,400;0,500;0,600;0,700;0,800;0,900;1,100;1,200;1,300;1,400;1,500;1,600;1,700;1,800;1,900&display=swap\");\n@import url(\"https://fonts.googleapis.com/css2?family=Work+Sans:ital,wght@0,100;0,200;0,300;0,400;0,500;0,600;0,700;0,800;0,900;1,100;1,200;1,300;1,400;1,500;1,600;1,700;1,800;1,900&display=swap\");\n@import url(\"https://fonts.googleapis.com/css2?family=Work+Sans:ital,wght@0,100;0,200;0,300;0,400;0,500;0,600;0,700;0,800;0,900;1,100;1,200;1,300;1,400;1,500;1,600;1,700;1,800;1,900&display=swap\");\n@import url(\"https://fonts.googleapis.com/css2?family=Spline+Sans+Mono:ital,wght@0,100;0,200;0,300;0,400;0,500;0,600;0,700;0,800;0,900;1,100;1,200;1,300;1,400;1,500;1,600;1,700;1,800;1,900&display=swap\");\n#mpxckuhipz table {\n  font-family: 'Spline Sans Mono', system-ui, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';\n  -webkit-font-smoothing: antialiased;\n  -moz-osx-font-smoothing: grayscale;\n}\n\n#mpxckuhipz thead, #mpxckuhipz tbody, #mpxckuhipz tfoot, #mpxckuhipz tr, #mpxckuhipz td, #mpxckuhipz th {\n  border-style: none;\n}\n\n#mpxckuhipz p {\n  margin: 0;\n  padding: 0;\n}\n\n#mpxckuhipz .gt_table {\n  display: table;\n  border-collapse: collapse;\n  line-height: normal;\n  margin-left: auto;\n  margin-right: auto;\n  color: #333333;\n  font-size: 14px;\n  font-weight: 500;\n  font-style: normal;\n  background-color: #FFFFFF;\n  width: 100%;\n  border-top-style: none;\n  border-top-width: 2px;\n  border-top-color: #A8A8A8;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #A8A8A8;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n}\n\n#mpxckuhipz .gt_caption {\n  padding-top: 4px;\n  padding-bottom: 4px;\n}\n\n#mpxckuhipz .gt_title {\n  color: #333333;\n  font-size: 26px;\n  font-weight: initial;\n  padding-top: 4px;\n  padding-bottom: 4px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-bottom-color: #FFFFFF;\n  border-bottom-width: 0;\n}\n\n#mpxckuhipz .gt_subtitle {\n  color: #333333;\n  font-size: 85%;\n  font-weight: initial;\n  padding-top: 3px;\n  padding-bottom: 5px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-color: #FFFFFF;\n  border-top-width: 0;\n}\n\n#mpxckuhipz .gt_heading {\n  background-color: #FFFFFF;\n  text-align: left;\n  border-bottom-color: #FFFFFF;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#mpxckuhipz .gt_bottom_border {\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#mpxckuhipz .gt_col_headings {\n  border-top-style: none;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 1px;\n  border-bottom-color: #000000;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n}\n\n#mpxckuhipz .gt_col_heading {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: 500;\n  text-transform: inherit;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 6px;\n  padding-left: 5px;\n  padding-right: 5px;\n  overflow-x: hidden;\n}\n\n#mpxckuhipz .gt_column_spanner_outer {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: 500;\n  text-transform: inherit;\n  padding-top: 0;\n  padding-bottom: 0;\n  padding-left: 4px;\n  padding-right: 4px;\n}\n\n#mpxckuhipz .gt_column_spanner_outer:first-child {\n  padding-left: 0;\n}\n\n#mpxckuhipz .gt_column_spanner_outer:last-child {\n  padding-right: 0;\n}\n\n#mpxckuhipz .gt_column_spanner {\n  border-bottom-style: solid;\n  border-bottom-width: 1px;\n  border-bottom-color: #000000;\n  vertical-align: bottom;\n  padding-top: 5px;\n  padding-bottom: 5px;\n  overflow-x: hidden;\n  display: inline-block;\n  width: 100%;\n}\n\n#mpxckuhipz .gt_spanner_row {\n  border-bottom-style: hidden;\n}\n\n#mpxckuhipz .gt_group_heading {\n  padding-top: 1.5px;\n  padding-bottom: 1.5px;\n  padding-left: 5px;\n  padding-right: 5px;\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-top-style: none;\n  border-top-width: 2px;\n  border-top-color: #000000;\n  border-bottom-style: solid;\n  border-bottom-width: 1px;\n  border-bottom-color: #000000;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n  text-align: left;\n}\n\n#mpxckuhipz .gt_empty_group_heading {\n  padding: 0.5px;\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  border-top-style: none;\n  border-top-width: 2px;\n  border-top-color: #000000;\n  border-bottom-style: solid;\n  border-bottom-width: 1px;\n  border-bottom-color: #000000;\n  vertical-align: middle;\n}\n\n#mpxckuhipz .gt_from_md > :first-child {\n  margin-top: 0;\n}\n\n#mpxckuhipz .gt_from_md > :last-child {\n  margin-bottom: 0;\n}\n\n#mpxckuhipz .gt_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  margin: 10px;\n  border-top-style: solid;\n  border-top-width: 1px;\n  border-top-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 1px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 1px;\n  border-right-color: #D3D3D3;\n  vertical-align: middle;\n  overflow-x: hidden;\n}\n\n#mpxckuhipz .gt_stub {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-right-style: solid;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#mpxckuhipz .gt_stub_row_group {\n  color: #333333;\n  background-color: #FFFFFF;\n  font-size: 100%;\n  font-weight: initial;\n  text-transform: inherit;\n  border-right-style: solid;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n  padding-left: 5px;\n  padding-right: 5px;\n  vertical-align: top;\n}\n\n#mpxckuhipz .gt_row_group_first td {\n  border-top-width: 2px;\n}\n\n#mpxckuhipz .gt_row_group_first th {\n  border-top-width: 2px;\n}\n\n#mpxckuhipz .gt_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#mpxckuhipz .gt_first_summary_row {\n  border-top-style: solid;\n  border-top-color: #D3D3D3;\n}\n\n#mpxckuhipz .gt_first_summary_row.thick {\n  border-top-width: 2px;\n}\n\n#mpxckuhipz .gt_last_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#mpxckuhipz .gt_grand_summary_row {\n  color: #333333;\n  background-color: #FFFFFF;\n  text-transform: inherit;\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#mpxckuhipz .gt_first_grand_summary_row {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-top-style: double;\n  border-top-width: 6px;\n  border-top-color: #D3D3D3;\n}\n\n#mpxckuhipz .gt_last_grand_summary_row_top {\n  padding-top: 8px;\n  padding-bottom: 8px;\n  padding-left: 5px;\n  padding-right: 5px;\n  border-bottom-style: double;\n  border-bottom-width: 6px;\n  border-bottom-color: #D3D3D3;\n}\n\n#mpxckuhipz .gt_striped {\n  background-color: rgba(128, 128, 128, 0.05);\n}\n\n#mpxckuhipz .gt_table_body {\n  border-top-style: none;\n  border-top-width: 2px;\n  border-top-color: #D3D3D3;\n  border-bottom-style: solid;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n}\n\n#mpxckuhipz .gt_footnotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#mpxckuhipz .gt_footnote {\n  margin: 0px;\n  font-size: 90%;\n  padding-top: 4px;\n  padding-bottom: 4px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#mpxckuhipz .gt_sourcenotes {\n  color: #333333;\n  background-color: #FFFFFF;\n  border-bottom-style: none;\n  border-bottom-width: 2px;\n  border-bottom-color: #D3D3D3;\n  border-left-style: none;\n  border-left-width: 2px;\n  border-left-color: #D3D3D3;\n  border-right-style: none;\n  border-right-width: 2px;\n  border-right-color: #D3D3D3;\n}\n\n#mpxckuhipz .gt_sourcenote {\n  font-size: 10px;\n  padding-top: 4px;\n  padding-bottom: 4px;\n  padding-left: 5px;\n  padding-right: 5px;\n}\n\n#mpxckuhipz .gt_left {\n  text-align: left;\n}\n\n#mpxckuhipz .gt_center {\n  text-align: center;\n}\n\n#mpxckuhipz .gt_right {\n  text-align: right;\n  font-variant-numeric: tabular-nums;\n}\n\n#mpxckuhipz .gt_font_normal {\n  font-weight: normal;\n}\n\n#mpxckuhipz .gt_font_bold {\n  font-weight: bold;\n}\n\n#mpxckuhipz .gt_font_italic {\n  font-style: italic;\n}\n\n#mpxckuhipz .gt_super {\n  font-size: 65%;\n}\n\n#mpxckuhipz .gt_footnote_marks {\n  font-size: 75%;\n  vertical-align: 0.4em;\n  position: initial;\n}\n\n#mpxckuhipz .gt_asterisk {\n  font-size: 100%;\n  vertical-align: 0;\n}\n\n#mpxckuhipz .gt_indent_1 {\n  text-indent: 5px;\n}\n\n#mpxckuhipz .gt_indent_2 {\n  text-indent: 10px;\n}\n\n#mpxckuhipz .gt_indent_3 {\n  text-indent: 15px;\n}\n\n#mpxckuhipz .gt_indent_4 {\n  text-indent: 20px;\n}\n\n#mpxckuhipz .gt_indent_5 {\n  text-indent: 25px;\n}\n\n#mpxckuhipz .katex-display {\n  display: inline-flex !important;\n  margin-bottom: 0.75em !important;\n}\n\n#mpxckuhipz div.Reactable > div.rt-table > div.rt-thead > div.rt-tr.rt-tr-group-header > div.rt-th-group:after {\n  height: 0px !important;\n}\n\n#mpxckuhipz tbody tr:last-child {\n  border-bottom: 2px solid #ffffff00;\n}\n\n#mpxckuhipz .gt_subtitle {\n  padding-top: 0px !important;\n  padding-bottom: 4px !important;\n}\n\n#mpxckuhipz .gt_sourcenote {\n  border-bottom-color: #FFFDF5 !important;\n}\n\n#mpxckuhipz .gt_heading {\n  padding-bottom: 0px;\n  padding-top: 6px;\n}\n</style>\n<table class=\"gt_table\" data-quarto-disable-processing=\"true\" data-quarto-bootstrap=\"false\">\n  \n  <tbody class=\"gt_table_body\">\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>AGG_ID</u></b>:<br><br>The Aggregation Group ID. The aggregation group for a subsidiary ESRD facility includes all ESRD facilities owned in whole or in part by the same legal entity located in the same Hospital Referral Region in which the ESRD facility is located. An ESRD facility that is not a Subsidiary ESRD facility is not included in an aggregation group but will have its own aggregation group ID.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>HRR_NUM_MY</u></b>:<br><br>The Hospital Referral Region number during the Measurement Year.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>HDR_MY</u></b>:<br><br>For Measurement Year 1 and Measurement Year 2, the Home Dialysis Rate for an aggregation group is the percent of attributed ESRD beneficiary months in which ESRD beneficiaries received dialysis at home or self-dialysis in-center during the Measurement Year. For Measurement Year 3 through Measurement Year 10, the Home Dialysis Rate for an aggregation group is the percent of attributed ESRD beneficiary months in which ESRD beneficiaries received dialysis at home, or self-dialysis in-center, or nocturnal in-center dialysis. The same Home Dialysis Rate is used for achievement scoring and improvement scoring.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>HDR_DNM_MY</u></b>:<br><br>The Home Dialysis Rate's denominator is the number of attributed ESRD beneficiary months at the aggregation group level during the Measurement Year.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>HDR_NUM_MY</u></b>:<br><br>For Measurement Year 1 and Measurement Year 2, the Home Dialysis Rate's numerator is the number of home dialysis treatment beneficiary months for attributed ESRD beneficiaries during the Measurement Year plus one half the total number of self-dialysis in-center treatment beneficiary months. For Measurement Year 3 through Measurement Year 10, the Home Dialysis Rate's numerator is the number of home dialysis treatment beneficiary months for attributed ESRD beneficiaries during the Measurement Year, plus one half the total number of self-dialysis in-center treatment beneficiary months, plus one half the total number of nocturnal in-center dialysis treatment beneficiary months.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>HD_NUM_MY</u></b>:<br><br>The number of months during which attributed ESRD beneficiaries received maintenance dialysis at home.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>SD_NUM_MY</u></b>:<br><br>The number of months during which attributed ESRD beneficiaries received self-dialysis in-center.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>NOCD_NUM_MY</u></b>:<br><br>The number of months during which attributed ESRD beneficiaries received nocturnal in-center dialysis. This variable is only applicable from Measurement Year 3 onwards.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>TR_MY_ACHSCR</u></b>:<br><br>The Transplant Rate for an aggregation group of ESRD facilities is the sum of the Transplant Waitlist Rate and Living Donor Transplant Rate. The Transplant Rate displayed here is used for achievement scoring. For transplant, the achievement scoring rate differs slightly from the improvement scoring rate due to differences in reference population groups used for risk adjusting transplant waitlist rates in the Measurement Year.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>TR_MY_IMPSCR</u></b>:<br><br>The Transplant Rate for an aggregation group of ESRD facilities is the sum of the Transplant Waitlist Rate and Living Donor Transplant Rate. The Transplant Waitlist Rate and Living Donor Transplant Rate do not include beneficiary months from beneficiaries who are 75 years of age or older at any point during the month. For Measurement Year 3 through Measurement Year 10, the Transplant Waitlist Rate and Living Donor Transplant Rate also do not include beneficiary months from beneficiaries who had a vital solid organ cancer diagnosis and were receiving treatment with chemotherapy or radiation for vital solid organ cancer during the Measurement Year. The Transplant Rate displayed here is used for improvement scoring. For transplant, the achievement scoring rate differs slightly from the improvement scoring rate due to differences in reference population groups used for risk adjusting transplant waitlist rates in the Measurement Year.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>TWR_DNM_MY</u></b>:<br><br>The Transplant Waitlist Rate's denominator is the number of attributed ESRD beneficiary months at the aggregation group level during the Measurement Year.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>TWR_NUM_MY</u></b>:<br><br>The Transplant Waitlist Rate's numerator is the number of attributed ESRD beneficiary months at the aggregation group level during the Measurement Year for which attributed ESRD beneficiaries were on the kidney transplant waitlist.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>LDT_DNM_MY</u></b>:<br><br>The Living Donor Transplant Rate's denominator is the number of attributed ESRD beneficiary months at the aggregation group level during the Measurement Year. For each aggregation group of ESRD facilities, the Living Donor Transplant Rate's denominator is the same as its Transplant Waitlist Rate's denominator.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>LDT_NUM_MY</u></b>:<br><br>The Living Donor Transplant Rate's numerator is the number of attributed beneficiary months for living donor transplant beneficiaries at the aggregation group level during the Measurement Year. Beneficiary months included in the numerator are composed of those months between the beginning of the Measurement Year up to and including the month of the transplant for Living Donor Transplant beneficiaries attributed to an ESRD facility during the month of the transplant.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>BENECNT_LDT_MY</u></b>:<br><br>The number of Living Donor Transplant beneficiaries during the Measurement Year.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>HEI_HDR</u></b>:<br><br>From Measurement Year 3 onwards, CMS incentivizes ETC Participants to decrease disparities in the Home Dialysis Rate and the Transplant Rate between beneficiaries who are dual-eligible or Low-Income Subsidy recipients (DE/LIS) and those who are not by adding a Health Equity Incentive to the improvement scoring methodology. An ETC Participant earns the Health Equity Incentive for the Home Dialysis Rate improvement score if the Home Dialysis Rate for the Measurement Year is at least 2.5 percentage points higher than the corresponding Benchmark Year rate for attributed ESRD beneficiaries who are dual-eligible or DE/LIS. If the ETC Participant earns the Health Equity Incentive for the Home Dialysis Rate improvement score, CMS adds 0.5 points to the ETC Participant's Home Dialysis Rate improvement score. This variable is only applicable from Measurement Year 3 onwards.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>HDR_DELIS_DIFF</u></b>:<br><br>The difference between the Benchmark Year and Measurement Year in the Home Dialysis Rate for attributed ESRD beneficiaries who are dual eligible or Low Income Subsidy recipients (DE/LIS). This variable is only applicable from Measurement Year 3 onwards.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>HDR_DELIS_MY</u></b>:<br><br>The Home Dialysis Rate in the Measurement Year for attributed ESRD beneficiaries who are dual eligible or Low Income Subsidy recipients (DE/LIS). This variable is only applicable from Measurement Year 3 onwards.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>HDR_DNM_DELIS_MY</u></b>:<br><br>The Health Equity Incentive Home Dialysis Rate's denominator is the number of attributed ESRD beneficiary months at the aggregation group level during the Measurement Year for attributed ESRD beneficiaries who are dual eligible or Low Income Subsidy recipients (DE/LIS). This variable is only applicable from Measurement Year 3 onwards.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>HDR_NUM_DELIS_MY</u></b>:<br><br>The Health Equity Incentive Home Dialysis Rate's numerator is the number of home dialysis treatment beneficiary months, plus one half the total number of self-dialysis in-center treatment beneficiary months, plus one half the total number of nocturnal in-center dialysis treatment beneficiary months during the Measurement Year, for attributed ESRD beneficiaries who are dual eligible or Low Income Subsidy recipients (DE/LIS). This variable is only applicable from Measurement Year 3 onwards.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>HEI_TR</u></b>:<br><br>From Measurement Year 3 onwards, CMS incentivizes ETC Participants to decrease disparities in the Home Dialysis Rate and the Transplant Rate between beneficiaries who are dual-eligible or Low-Income Subsidy recipients (DE/LIS) and those who are not by adding a Health Equity Incentive to the improvement scoring methodology. An ETC Participant earns the Health Equity Incentive for the Transplant Rate improvement score if the Transplant Rate for the Measurement Year is at least 2.5 percentage points higher than the corresponding Benchmark Year rate for attributed ESRD beneficiaries who are dual-eligible or DE/LIS. If the ETC Participant earns the Health Equity Incentive for the Transplant Rate improvement score, CMS adds 0.5 points to the ETC Participant's transplant rate improvement score. This variable is only applicable from Measurement Year 3 onwards.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>TR_DELIS_DIFF</u></b>:<br><br>The difference between the Benchmark Year and Measurement Year in the Transplant Rate for attributed ESRD beneficiaries who are dual eligible or Low Income Subsidy recipients (DE/LIS). This variable is only applicable from Measurement Year 3 onwards.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>TR_DELIS_MY</u></b>:<br><br>The Transplant Rate in the Measurement Year for attributed ESRD beneficiaries who are dual eligible or Low Income Subsidy recipients (DE/LIS). This variable is only applicable from Measurement Year 3 onwards.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>TWR_DNM_DELIS_MY</u></b>:<br><br>The number of dual eligible or Low Income Subsidy recipient (DE/LIS) beneficiary months at the aggregation group level during the Measurement Year included in the Health Equity Incentive Transplant Waitlist Rate denominator. This variable is only applicable from Measurement Year 3 onwards.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>TWR_NUM_DELIS_MY</u></b>:<br><br>The number of dual eligible or Low Income Subsidy (DE/LIS) beneficiary months at the aggregation group level during the Measurement Year for which DE/LIS beneficiaries were on the kidney transplant waitlist. This variable is only applicable from Measurement Year 3 onwards.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>LDT_DNM_DELIS_MY</u></b>:<br><br>The number of dual eligible or Low Income Subsidy (DE/LIS) beneficiary months at the aggregation group level during the Measurement Year. For each aggregation group of ESRD facilities, the Living Donor Transplant Rate's denominator is the same as its Transplant Waitlist Rate's denominator. This variable is only applicable from Measurement Year 3 onwards.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>LDT_NUM_DELIS_MY</u></b>:<br><br>The number of dual eligible or Low Income Subsidy (DE/LIS) beneficiary months for living donor transplant beneficiaries at the aggregation group level during the Measurement Year. This variable is only applicable from Measurement Year 3 onwards.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>MPS</u></b>:<br><br>The Modality Performance Score is a weighted sum of the higher of the achievement score or the improvement score for the ETC Participant's Home Dialysis Rate and Transplant Rate. For Measurement Year 1 and Measurement Year 2 the MPS=2Ã—(The higher of the home dialysis rate achievement or improvement score)+(The higher of the transplant rate achievement or improvement score). For Measurement Year 3 through Measurement Year 10, the MPS=2Ã—(The higher of the home dialysis achievement or (home dialysis improvement score + Health Equity Bonus))+(The higher of the transplant achievement or (transplant improvement score + Health Equity Bonus)).</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>PPA</u></b>:<br><br>The Performance Period Adjustment (PPA) is an upward or downward payment adjustment that is made on all dialysis claims with claim service dates during the corresponding PPA period based on an ETC Participant's Home Dialysis Rate and Transplant Rate related performance during the Measurement Year.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>PPA_PERIOD</u></b>:<br><br>The 6-month period during which the payments are adjusted based on ETC Participants' performance in each Measurement Year.</td></tr>\n    <tr><td headers=\"field\" class=\"gt_row gt_left\" style=\"border-top-width: 1.5px; border-top-style: dotted; border-top-color: black;\"><b><u>MY</u></b>:<br><br>The 12-month period for which achievement and improvement on the home dialysis rate and transplant rate are assessed for the purpose of calculating ETC Participants' MPS and PPA.</td></tr>\n  </tbody>\n  \n  \n</table>\n</div>\n```\n</code></pre>\n`````\n:::\n:::\n\n## Data\n\n::: {.cell}\n<pre class=\"r-output\"><code><span style='color: #555555;'># A tibble: 421 Ã— 31</span>\n   AGG_ID HRR_NUM_MY HDR_MY HDR_DNM_MY HDR_NUM_MY HD_NUM_MY SD_NUM_MY\n   <span style='color: #555555; font-style: italic;'><chr></span>  <span style='color: #555555; font-style: italic;'><fct></span>       <span style='color: #555555; font-style: italic;'><dbl></span>      <span style='color: #555555; font-style: italic;'><dbl></span>      <span style='color: #555555; font-style: italic;'><dbl></span>     <span style='color: #555555; font-style: italic;'><dbl></span>     <span style='color: #555555; font-style: italic;'><dbl></span>\n<span style='color: #555555;'> 1</span> DF5698 12          0          -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>      -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>     -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>     -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>\n<span style='color: #555555;'> 2</span> DF0368 22         10          -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>      -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>     -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>     -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>\n<span style='color: #555555;'> 3</span> DF1214 22          2.44       -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>      -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>     -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>     -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>\n<span style='color: #555555;'> 4</span> DF6486 21          0            178          0         0         0\n<span style='color: #555555;'> 5</span> DF2496 80          0          -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>      -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>     -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>     -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>\n<span style='color: #555555;'> 6</span> DF2368 80          0            396          0         0         0\n<span style='color: #555555;'> 7</span> DF4436 80          0            701          0         0         0\n<span style='color: #555555;'> 8</span> DF9276 280         0.444        225      -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>998</span>     -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>998</span>         0\n<span style='color: #555555;'> 9</span> DF3832 139        19.4        -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>      -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>     -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>     -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>\n<span style='color: #555555;'>10</span> DF2884 123         0          -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>      -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>     -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>     -<span style='color: #BB0000; text-decoration: underline;'>9</span><span style='color: #BB0000;'>999</span>\n<span style='color: #555555;'># â„¹ 411 more rows</span>\n<span style='color: #555555;'># â„¹ 24 more variables: NOCD_NUM_MY <dbl>, TR_MY_ACHSCR <dbl>,</span>\n<span style='color: #555555;'>#   TR_MY_IMPSCR <dbl>, TWR_DNM_MY <dbl>, TWR_NUM_MY <dbl>, LDT_DNM_MY <dbl>,</span>\n<span style='color: #555555;'>#   LDT_NUM_MY <dbl>, BENECNT_LDT_MY <dbl>, HEI_HDR <dbl>,</span>\n<span style='color: #555555;'>#   HDR_DELIS_DIFF <dbl>, HDR_DELIS_MY <dbl>, HDR_DNM_DELIS_MY <dbl>,</span>\n<span style='color: #555555;'>#   HDR_NUM_DELIS_MY <dbl>, HEI_TR <dbl>, TR_DELIS_DIFF <dbl>,</span>\n<span style='color: #555555;'>#   TR_DELIS_MY <dbl>, TWR_DNM_DELIS_MY <dbl>, TWR_NUM_DELIS_MY <dbl>, â€¦</span>\n</code></pre>\n:::\n\n## Overview\n\n::: {.cell}\n<pre class=\"r-output\"><code><span style='color: #0000BB;'>resp (421 rows and 31 variables, 31 shown)</span>\n\nID | Name             | Type        |    Missings |          Values |            N\n---+------------------+-------------+-------------+-----------------+-------------\n1  | AGG_ID           | character   |    0 (0.0%) |          DF0018 |   1 (  0.2%)\n   |                  |             |             |          DF0020 |   1 (  0.2%)\n   |                  |             |             |          DF0028 |   1 (  0.2%)\n   |                  |             |             |          DF0094 |   1 (  0.2%)\n   |                  |             |             |          DF0120 |   1 (  0.2%)\n   |                  |             |             |          DF0126 |   1 (  0.2%)\n   |                  |             |             |          DF0166 |   1 (  0.2%)\n   |                  |             |             |          DF0196 |   1 (  0.2%)\n   |                  |             |             |          DF0240 |   1 (  0.2%)\n   |                  |             |             |          DF0246 |   1 (  0.2%)\n   |                  |             |             |           (...) |             \n---+------------------+-------------+-------------+-----------------+-------------\n2  | HRR_NUM_MY       | categorical |    0 (0.0%) |              10 |   2 (  0.5%)\n   |                  |             |             |             104 |   3 (  0.7%)\n   |                  |             |             |             111 |   4 (  1.0%)\n   |                  |             |             |             113 |   8 (  1.9%)\n   |                  |             |             |             119 |   5 (  1.2%)\n   |                  |             |             |              12 |   7 (  1.7%)\n   |                  |             |             |             120 |   4 (  1.0%)\n   |                  |             |             |             122 |   3 (  0.7%)\n   |                  |             |             |             123 |   7 (  1.7%)\n   |                  |             |             |             129 |   2 (  0.5%)\n   |                  |             |             |           (...) |             \n---+------------------+-------------+-------------+-----------------+-------------\n3  | HDR_MY           | numeric     |   30 (7.1%) |        [0, 100] |          391\n---+------------------+-------------+-------------+-----------------+-------------\n4  | HDR_DNM_MY       | numeric     |   30 (7.1%) |  [-9999, 14593] |          391\n---+------------------+-------------+-------------+-----------------+-------------\n5  | HDR_NUM_MY       | numeric     |   30 (7.1%) | [-9999, 1810.5] |          391\n---+------------------+-------------+-------------+-----------------+-------------\n6  | HD_NUM_MY        | numeric     |   30 (7.1%) |   [-9999, 1798] |          391\n---+------------------+-------------+-------------+-----------------+-------------\n7  | SD_NUM_MY        | numeric     |   30 (7.1%) |           -9999 |  80 ( 20.5%)\n   |                  |             |             |           -9998 |   8 (  2.0%)\n   |                  |             |             |               0 | 300 ( 76.7%)\n   |                  |             |             |              42 |   2 (  0.5%)\n   |                  |             |             |              84 |   1 (  0.3%)\n---+------------------+-------------+-------------+-----------------+-------------\n8  | NOCD_NUM_MY      | numeric     |   30 (7.1%) |    [-9999, 135] |          391\n---+------------------+-------------+-------------+-----------------+-------------\n9  | TR_MY_ACHSCR     | numeric     |   30 (7.1%) |      [0, 97.16] |          391\n---+------------------+-------------+-------------+-----------------+-------------\n10 | TR_MY_IMPSCR     | numeric     |   30 (7.1%) |      [0, 78.51] |          391\n---+------------------+-------------+-------------+-----------------+-------------\n11 | TWR_DNM_MY       | numeric     |   30 (7.1%) |  [-9999, 10812] |          391\n---+------------------+-------------+-------------+-----------------+-------------\n12 | TWR_NUM_MY       | numeric     |   30 (7.1%) |   [-9999, 2575] |          391\n---+------------------+-------------+-------------+-----------------+-------------\n13 | LDT_DNM_MY       | numeric     |   30 (7.1%) |  [-9999, 10812] |          391\n---+------------------+-------------+-------------+-----------------+-------------\n14 | LDT_NUM_MY       | numeric     |   30 (7.1%) |     [-9999, 78] |          391\n---+------------------+-------------+-------------+-----------------+-------------\n15 | BENECNT_LDT_MY   | numeric     |   30 (7.1%) |           -9999 |  80 ( 20.5%)\n   |                  |             |             |           -9998 | 147 ( 37.6%)\n   |                  |             |             |               0 | 162 ( 41.4%)\n   |                  |             |             |              12 |   2 (  0.5%)\n---+------------------+-------------+-------------+-----------------+-------------\n16 | HEI_HDR          | numeric     | 165 (39.2%) |               0 | 171 ( 66.8%)\n   |                  |             |             |             0.5 |  85 ( 33.2%)\n---+------------------+-------------+-------------+-----------------+-------------\n17 | HDR_DELIS_DIFF   | numeric     |   35 (8.3%) |   [-100, 58.18] |          386\n---+------------------+-------------+-------------+-----------------+-------------\n18 | HDR_DELIS_MY     | numeric     |   33 (7.8%) |        [0, 100] |          388\n---+------------------+-------------+-------------+-----------------+-------------\n19 | HDR_DNM_DELIS_MY | numeric     |   30 (7.1%) |   [-9999, 8680] |          391\n---+------------------+-------------+-------------+-----------------+-------------\n20 | HDR_NUM_DELIS_MY | numeric     |   30 (7.1%) |   [-9999, 1085] |          391\n---+------------------+-------------+-------------+-----------------+-------------\n21 | HEI_TR           | numeric     | 171 (40.6%) |               0 | 178 ( 71.2%)\n   |                  |             |             |             0.5 |  72 ( 28.8%)\n---+------------------+-------------+-------------+-----------------+-------------\n22 | TR_DELIS_DIFF    | numeric     |   37 (8.8%) | [-58.73, 61.71] |          384\n---+------------------+-------------+-------------+-----------------+-------------\n23 | TR_DELIS_MY      | numeric     |   35 (8.3%) |      [0, 61.93] |          386\n---+------------------+-------------+-------------+-----------------+-------------\n24 | TWR_DNM_DELIS_MY | numeric     |   30 (7.1%) |   [-9999, 7366] |          391\n---+------------------+-------------+-------------+-----------------+-------------\n25 | TWR_NUM_DELIS_MY | numeric     |   30 (7.1%) |   [-9999, 1766] |          391\n---+------------------+-------------+-------------+-----------------+-------------\n26 | LDT_DNM_DELIS_MY | numeric     |   30 (7.1%) |   [-9999, 7366] |          391\n---+------------------+-------------+-------------+-----------------+-------------\n27 | LDT_NUM_DELIS_MY | numeric     |   30 (7.1%) |     [-9999, 36] |          391\n---+------------------+-------------+-------------+-----------------+-------------\n28 | MPS              | numeric     |   30 (7.1%) |          [0, 6] |          391\n---+------------------+-------------+-------------+-----------------+-------------\n29 | PPA              | numeric     | 110 (26.1%) |              -6 |  15 (  4.8%)\n   |                  |             |             |              -3 |  78 ( 25.1%)\n   |                  |             |             |               0 |  79 ( 25.4%)\n   |                  |             |             |             2.5 | 104 ( 33.4%)\n   |                  |             |             |               5 |  35 ( 11.3%)\n---+------------------+-------------+-------------+-----------------+-------------\n30 | PPA_PERIOD       | categorical |    0 (0.0%) |               4 | 421 (100.0%)\n---+------------------+-------------+-------------+-----------------+-------------\n31 | MY               | categorical |    0 (0.0%) |               4 | 421 (100.0%)\n----------------------------------------------------------------------------------\n</code></pre>\n:::\n\n### Distribution\n\n::: {.cell}\n<pre class=\"r-output\"><code>Variable         |     Mean |      SD |      IQR |                Range\n-----------------------------------------------------------------------\nHDR_MY           |    16.31 |   18.17 |    17.53 |       [0.00, 100.00]\nHDR_DNM_MY       |  -619.72 | 5163.20 |  1578.00 | [-9999.00, 14593.00]\nHDR_NUM_MY       | -2271.66 | 4485.31 | 10310.00 |  [-9999.00, 1810.50]\nHD_NUM_MY        | -2298.45 | 4499.93 | 10310.00 |  [-9999.00, 1798.00]\nSD_NUM_MY        | -2249.96 | 4181.37 |     0.00 |    [-9999.00, 84.00]\nNOCD_NUM_MY      | -2657.19 | 4425.10 |  9998.00 |   [-9999.00, 135.00]\nTR_MY_ACHSCR     |    19.43 |   13.17 |    14.23 |        [0.00, 97.16]\nTR_MY_IMPSCR     |    15.92 |   10.77 |    11.53 |        [0.00, 78.51]\nTWR_DNM_MY       |  -967.62 | 4836.21 |  1173.00 | [-9999.00, 10812.00]\nTWR_NUM_MY       | -2044.37 | 4304.54 |   233.00 |  [-9999.00, 2575.00]\nLDT_DNM_MY       |  -967.62 | 4836.21 |  1173.00 | [-9999.00, 10812.00]\nLDT_NUM_MY       | -3548.77 | 4796.35 |  9998.00 |    [-9999.00, 78.00]\nBENECNT_LDT_MY   | -5804.61 | 4940.25 |  9998.00 |    [-9999.00, 12.00]\nHEI_HDR          |     0.17 |    0.24 |     0.50 |         [0.00, 0.50]\nHDR_DELIS_DIFF   |     0.14 |   10.25 |     4.25 |     [-100.00, 58.18]\nHDR_DELIS_MY     |    13.57 |   18.12 |    16.72 |       [0.00, 100.00]\nHDR_DNM_DELIS_MY | -1425.62 | 4450.43 |   645.00 |  [-9999.00, 8680.00]\nHDR_NUM_DELIS_MY | -2530.29 | 4444.08 | 10100.00 |  [-9999.00, 1085.00]\nHEI_TR           |     0.14 |    0.23 |     0.50 |         [0.00, 0.50]\nTR_DELIS_DIFF    |    -0.44 |   10.98 |     6.62 |      [-58.73, 61.71]\nTR_DELIS_MY      |    15.14 |   12.56 |    12.70 |        [0.00, 61.93]\nTWR_DNM_DELIS_MY | -1492.99 | 4396.20 |   563.00 |  [-9999.00, 7366.00]\nTWR_NUM_DELIS_MY | -2618.67 | 4509.37 | 10102.00 |  [-9999.00, 1766.00]\nLDT_DNM_DELIS_MY | -1492.99 | 4396.20 |   563.00 |  [-9999.00, 7366.00]\nLDT_NUM_DELIS_MY | -3527.49 | 4785.35 |  9998.00 |    [-9999.00, 36.00]\nMPS              |     3.08 |    1.65 |     3.00 |         [0.00, 6.00]\nPPA              |     0.36 |    2.97 |     5.50 |        [-6.00, 5.00]\n\nVariable         | Skewness | Kurtosis |   n | n_Missing\n--------------------------------------------------------\nHDR_MY           |     2.79 |    10.10 | 391 |        30\nHDR_DNM_MY       |    -0.78 |     0.09 | 391 |        30\nHDR_NUM_MY       |    -1.14 |    -0.68 | 391 |        30\nHD_NUM_MY        |    -1.12 |    -0.72 | 391 |        30\nSD_NUM_MY        |    -1.32 |    -0.25 | 391 |        30\nNOCD_NUM_MY      |    -1.06 |    -0.87 | 391 |        30\nTR_MY_ACHSCR     |     1.46 |     4.38 | 391 |        30\nTR_MY_IMPSCR     |     1.44 |     4.27 | 391 |        30\nTWR_DNM_MY       |    -1.02 |     0.01 | 391 |        30\nTWR_NUM_MY       |    -1.30 |    -0.27 | 391 |        30\nLDT_DNM_MY       |    -1.02 |     0.01 | 391 |        30\nLDT_NUM_MY       |    -0.61 |    -1.64 | 391 |        30\nBENECNT_LDT_MY   |     0.33 |    -1.90 | 391 |        30\nHEI_HDR          |     0.72 |    -1.50 | 256 |       165\nHDR_DELIS_DIFF   |    -3.10 |    32.81 | 386 |        35\nHDR_DELIS_MY     |     3.13 |    11.76 | 388 |        33\nHDR_DNM_DELIS_MY |    -1.28 |     0.06 | 391 |        30\nHDR_NUM_DELIS_MY |    -1.09 |    -0.81 | 391 |        30\nHEI_TR           |     0.94 |    -1.12 | 250 |       171\nTR_DELIS_DIFF    |    -0.15 |     8.94 | 384 |        37\nTR_DELIS_MY      |     1.36 |     2.21 | 386 |        35\nTWR_DNM_DELIS_MY |    -1.32 |     0.07 | 391 |        30\nTWR_NUM_DELIS_MY |    -1.03 |    -0.94 | 391 |        30\nLDT_DNM_DELIS_MY |    -1.32 |     0.07 | 391 |        30\nLDT_NUM_DELIS_MY |    -0.62 |    -1.63 | 391 |        30\nMPS              |    -0.04 |    -1.03 | 391 |        30\nPPA              |    -0.28 |    -0.78 | 311 |       110\n</code></pre>\n:::\n\n::: {.cell layout-ncol=\"3\"}\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-1.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-2.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-3.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-4.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-5.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-6.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-7.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-8.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-9.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-10.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-11.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-12.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-13.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-14.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-15.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-16.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-17.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-18.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-19.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-20.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-21.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-22.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-23.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-24.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-25.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-26.png){width=672}\n:::\n\n::: {.cell-output-display}\n![](care_esrdgrp_files/figure-html/distribution_plot-27.png){width=672}\n:::\n:::\n",
    "supporting": [
      "care_esrdgrp_files"
    ],
    "filters": [
      "rmarkdown/pagebreak.lua"
    ],
    "includes": {},
    "engineDependencies": {},
    "preserve": {},
    "postProcess": true
  }
}